CN101526532A - Narcotic saliva detection - Google Patents

Narcotic saliva detection Download PDF

Info

Publication number
CN101526532A
CN101526532A CN200810302091A CN200810302091A CN101526532A CN 101526532 A CN101526532 A CN 101526532A CN 200810302091 A CN200810302091 A CN 200810302091A CN 200810302091 A CN200810302091 A CN 200810302091A CN 101526532 A CN101526532 A CN 101526532A
Authority
CN
China
Prior art keywords
drugs
product
sample
colloid gold
gold label
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810302091A
Other languages
Chinese (zh)
Inventor
陈桂勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200810302091A priority Critical patent/CN101526532A/en
Publication of CN101526532A publication Critical patent/CN101526532A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention relates to narcotic saliva detection belonging to the field of biological medicines, biological separation, biological devices, reagents and relative detection reagents. A colloidal gold immunity tomography technology is very developed as a development platform technology for the product, but the development key of the product lies in the high sensitivity and the high specificity of a monoclonal antibody and the optimization of the product manufacture technological process. In order to evade the technological problems, the monoclonal antibody used for product development can be firstly separated so that monoclonal antibody stubs with the optimal sensitivity and the optimal specificity can be selected for protein labeling and can meet the special requirements for the saliva detection.

Description

Narcotic saliva detects
Affiliated technical field:
Biological medicine. bio-separation, device, reagent and coherent detection reagent.
Background technology:
The drugs quick detection reagent that is adopted on the domestic and international market all is to be that sample detects with the urine at present; The present greatest problem that faces of these series of products is exactly the sample dirt, defective such as mingle/substitute easily.And in the world cry day high property privacy and human rights issue.
Summary of the invention:
For overcome sample dirt that present drugs detect, mingle easily/substitute, defective such as the property invaded privacy. saliva detection will be clinical disease diagnosis. the forbidden drug of family health care self check and forensic science or drugs detect. open up a brand-new field.Its sampling method is simple, and Noninvasive, and sample totally and not has infectiousness, also can save great amount of manpower and material resources, and drug concentration and blood concentration in the saliva are closely related; This has just been avoided the infectiousness danger of blood testing and the sample dirt of urine detection, mingle easily/substitute, defectives such as the property invaded privacy, be easy to be accepted by the person under inspection, thereby it is this brand-new, fast, the detection means of Noninvasive will be subjected to using widely. and the saliva detection technique also can solve the variety of problems that the urine detection process occurs: the cross reaction between (1) forbidden drug/drugs and the non-prohibited substance, saliva is detected on the one hand and can be got rid of because of taking the false positive results that other non-prohibited substances produce, also can help drug law enforcement personnel and drugs appraiser to distinguish the true and false of drug addict's confession on the other hand, for drugs fighting work brings great convenience; (2) aspect new recruit, new life, civil servant, special practitioner (pilot, driver, work high above the ground person etc.) health check-up, saliva is detected on the one hand can prevent that the experimenter from mingling the manufacturing false positive in sample, attempt escape to be enlisted/the working obligation, can prevent from also on the other hand that the drug addict from arguing to take non-prohibited substance and get by under false pretences.Aspect the specificity that detects saliva, according to the pharmacokinetics principle, the major part that detected of saliva detection is a medicine itself in theory, but not its metabolic product; Therefore the specificity of saliva detection more is better than urine detection.And in the research and application process of reality, because monoclonal antibodies against morphine and morphine-BSA bond, anti-meth monoclonal antibody and meth-BSA bond that this research institute adopts have passed through a large amount of clinical verifications; Therefore from practical application, the specificity that saliva is detected also more is better than urine detection.
Technical scheme:
The product that this project is developed adopts collaurum competition inhibition method immunochromatography technique, and drugs are antigen coated on cellulose nitrate film, and bag is by the monoclonal antibody specific of colloid gold label on glass fibre.When detecting, if do not have morphine, meth or its metabolic product to exist in the sample, the specific antibody of colloid gold label and film district antigen and two resistive connections close, form a nature controlling line C respectively, article one, morphine response line MOR, a meth response line MET show that testing result is that morphine, meth are all negative.If only have morphine or its metabolic product in the sample, and concentration is higher than detection level (15 ± 5ng/ml) time, the drug numerator morphine just combines with the antibody competition of colloid gold label, thereby stop the antibody of colloid gold label to combine with film district antigen, the red response line MOR of its correspondence is disappeared, the nature controlling line C that a redness only occurs shows that testing result is the morphine positive, meth feminine gender.If only have meth or its metabolic product in the sample, and concentration is higher than detection level (50 ± 5ng/ml) time, the drug numerator meth just combines with the antibody competition of colloid gold label, thereby stop the antibody of colloid gold label to combine with film district antigen, the red response line MET of its correspondence is disappeared, nature controlling line C and a morphine response line MOR that a redness only occurs show that testing result is the meth positive, morphine feminine gender.If have morphine and meth or its metabolic product in the sample simultaneously, and concentration is higher than detection level (morphine 〉=15 ± 5ng/ml, during meth 〉=50 ± 5ng/ml), the colloid gold label antibody competition combination that drug numerator morphine and meth are just corresponding with it respectively, thereby stop the antibody of colloid gold label to combine with film district antigen, the red response line MOR and the MET of its correspondence are all disappeared, the nature controlling line C that a redness only occurs shows that testing result is that morphine and meth are all positive.
Embodiment:
This project product throw in on-the-spot on probation and obtain authoritative department and users' approval after, I start the declaration program at corporation plan, and take to promote trade and investment be main, to sell directly to households be the marketing strategy of assisting, product is taken registration certificate and is begun later on to produce in enormous quantities.My company has set up 100,000 grades cleaning at present, is carrying out quality of production system certification and is actively getting in touch clinical testing unit.Enterprise has veteran technical research personnel, has guaranteed the project maturity of technology; And set up marketing center's organizational structure, sell for product is formal and accomplished fluently certain basis.
Description of drawings:
Fig. 1 is that saliva sampler, Fig. 2 are that narcotic saliva detection components, Fig. 3 are, Fig. 4 is that saliva sampling, Fig. 5 are that narcotic saliva detects, Fig. 6 is that narcotic saliva detects, Fig. 7 is the narcotic saliva test card in the saliva sampling.

Claims (2)

1: a kind of saliva reagent that can detect drugs, this product are applicable to army's conscription, college entrance examination enrollment, unit recruitment, civil servant
Employ, driver's health check-up, public place of entertainment are checked, drug abuse generaI investigation and public security bureau, narcotic house and hospital etc. are single
Drugs/forbidden drug the inspection of position.This product is that drugs are antigen coated on cellulose nitrate film, wraps on glass fibre
By the specific antibody of colloid gold label.When detecting, there is not the collaurum mark as having drugs or its metabolic product in the sample
Specific antibody and the film district antigen of note and two resistive connections close two red lines of formation (a response line T, a nature controlling line C),
Show that testing result is negative; As having drugs or its metabolic product in the sample, and concentration is when being higher than detection level, drugs
Molecule just combines with the antibody competition of colloid gold label, thereby stops the antibody of colloid gold label to combine with film district antigen, makes it
Corresponding red response line disappears, and the nature controlling line of a redness only occurs, shows that testing result is positive.
2, technical characterictic: in view of the drugs quick detection reagent that is adopted on the present domestic and international market all is to be that sample is examined with the urine
Survey, defectives such as the present invention can overcome sample dirt that present drugs detect, mingles easily/substitute, the property invaded privacy this
The product that order is developed adopts collaurum competition inhibition method immunochromatography technique, and drugs are antigen coated at cellulose nitrate film
On, bag is by the monoclonal antibody specific of colloid gold label on glass fibre.When detecting, if do not have in the sample
Coffee, meth or its metabolic product exist, and the specific antibody of colloid gold label and film district antigen and two resistive connections close,
Form a nature controlling line C respectively, morphine response line MOR, a meth response line MET show that testing result is that morphine, meth are all negative.
CN200810302091A 2008-06-10 2008-06-10 Narcotic saliva detection Pending CN101526532A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810302091A CN101526532A (en) 2008-06-10 2008-06-10 Narcotic saliva detection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810302091A CN101526532A (en) 2008-06-10 2008-06-10 Narcotic saliva detection

Publications (1)

Publication Number Publication Date
CN101526532A true CN101526532A (en) 2009-09-09

Family

ID=41094508

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810302091A Pending CN101526532A (en) 2008-06-10 2008-06-10 Narcotic saliva detection

Country Status (1)

Country Link
CN (1) CN101526532A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108414513A (en) * 2017-06-09 2018-08-17 北京中生朗捷生物技术股份有限公司 Alcohol and drug test All-in-One sampling detector in DNA sample acquisition, saliva
CN108845151A (en) * 2018-05-29 2018-11-20 郑州左安检测科技有限公司 A kind of test strips and its preparation method and application method detecting crystal methamphetamine

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981298A (en) * 1995-12-13 1999-11-09 Surmodics, Inc. Immunoassay device and method
CN1259668A (en) * 1998-11-10 2000-07-12 长沙市精神病医院 Method and test paper of smei-quantitative determination of morphine by monoclone antibody immune chromatography
US6248598B1 (en) * 1998-09-17 2001-06-19 Stuart C. Bogema Immunoassay that provides for both collection of saliva and assay of saliva for one or more analytes with visual readout
CN1377300A (en) * 2000-09-19 2002-10-30 辛特朗生物研究公司 Multiple analyte assay device with sample integrity monitoring system
CN1410770A (en) * 2002-11-22 2003-04-16 上海凯创生物技术有限公司 Reagent box for fast detecting methyl amphetamine and its preparation process
CN1632583A (en) * 2004-12-30 2005-06-29 上海美康生物工程有限公司 Multi-in-one combined detection kit for drug and preparation process and enclosed reagent thereof
US20060127274A1 (en) * 2004-12-09 2006-06-15 Vallejo Yli R Assay device and process for the testing of fluid samples
CN2914090Y (en) * 2006-02-22 2007-06-20 万华普曼生物工程有限公司 Colloidal gold test paper for rapidly detecting amphetamine
US7244392B1 (en) * 2000-05-22 2007-07-17 Inverness Medical Switzerland Gmbh Slide-in cassette for a cup for testing of drugs of abuse
CN200989903Y (en) * 2006-10-27 2007-12-12 万华普曼生物工程有限公司 Poisonous drug five-in-one union detecting plate

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981298A (en) * 1995-12-13 1999-11-09 Surmodics, Inc. Immunoassay device and method
US6248598B1 (en) * 1998-09-17 2001-06-19 Stuart C. Bogema Immunoassay that provides for both collection of saliva and assay of saliva for one or more analytes with visual readout
CN1259668A (en) * 1998-11-10 2000-07-12 长沙市精神病医院 Method and test paper of smei-quantitative determination of morphine by monoclone antibody immune chromatography
US7244392B1 (en) * 2000-05-22 2007-07-17 Inverness Medical Switzerland Gmbh Slide-in cassette for a cup for testing of drugs of abuse
CN1377300A (en) * 2000-09-19 2002-10-30 辛特朗生物研究公司 Multiple analyte assay device with sample integrity monitoring system
CN1410770A (en) * 2002-11-22 2003-04-16 上海凯创生物技术有限公司 Reagent box for fast detecting methyl amphetamine and its preparation process
US20060127274A1 (en) * 2004-12-09 2006-06-15 Vallejo Yli R Assay device and process for the testing of fluid samples
CN1632583A (en) * 2004-12-30 2005-06-29 上海美康生物工程有限公司 Multi-in-one combined detection kit for drug and preparation process and enclosed reagent thereof
CN2914090Y (en) * 2006-02-22 2007-06-20 万华普曼生物工程有限公司 Colloidal gold test paper for rapidly detecting amphetamine
CN200989903Y (en) * 2006-10-27 2007-12-12 万华普曼生物工程有限公司 Poisonous drug five-in-one union detecting plate

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
姜燕 等: "吗啡和甲基氨基他明单克隆抗体联合胶体金件测试卡的研制", 《中国免疫学杂志》 *
彭和平 等: "胶体金层析法检测尿中吗啡的探讨", 《临床和实验医学杂志》 *
江静 等: "甲基苯丙胺免疫层析检测条的研制", 《同位素》 *
谢鑫 等: "抗吗啡单克隆抗体的制备及其胶体金交联物的初步应用", 《细胞与分子免疫学杂志》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108414513A (en) * 2017-06-09 2018-08-17 北京中生朗捷生物技术股份有限公司 Alcohol and drug test All-in-One sampling detector in DNA sample acquisition, saliva
CN108845151A (en) * 2018-05-29 2018-11-20 郑州左安检测科技有限公司 A kind of test strips and its preparation method and application method detecting crystal methamphetamine

Similar Documents

Publication Publication Date Title
EP1891447B1 (en) Two step lateral flow assay methods and devices
EP2780705B1 (en) Methods and systems for detecting an analyte in a sample
CN105264086B (en) For the method and kit of diagnosing influenza
CN201965131U (en) Quick test paper of hepatitis A virus (HAV) IgM antibody
CN103403547A (en) Counting particles using an electrical differential counter
CN107561270A (en) Use the sensitive immunoassays of coated nano particle
CN108535485A (en) A kind of time-resolved fluoroimmunoassay chromatograph test strip and preparation method quantitatively detecting CA153 in blood
CN101528942A (en) Methods and systems for detection of contaminants
Seo et al. Polydiacetylene liposome microarray toward facile measurement of platelet activation in whole blood
Lee et al. Method for the rapid detection of SARS-CoV-2-neutralizing antibodies using a nanogel-based surface plasmon resonance biosensor
CN101019023A (en) Chromatographic exclusion agglutination assay and methods of use thereof
EP2982987A1 (en) Lateral flow immunoassays for the detection of antibodies against biological drugs
CN101949926A (en) Human echinococcosis colloidal gold immunochromatographic assay urine testing quick diagnosis test paper card
CN101526532A (en) Narcotic saliva detection
CN105353116A (en) Method for immunoassay based on hydrogen peroxide test strip and applications
CN101762692A (en) Magnetic immunochromatographic strip for detection of tuberculosis (TB) antibody in blood and preparation method thereof
CN101339193B (en) Eperythrozoonosis rapid diagnosis test paper
Townsend et al. Salivary analysis of drugs—potential and difficulties
WO2018210395A1 (en) Lateral flow chromatographic assay for tuberculosis (tb)
WO2021247335A1 (en) Viral diagnostics
Zainuddin et al. Recent trends in dengue detection methods using biosensors
CN1139810C (en) Method and test paper of smei-quantitative determination of morphine by monoclone antibody immune chromatography
Jain Self-reported drug use and urinalysis results
Reed Generating appropriate technologies for Health Equity: José Luis Fernández Yero, MD, PhD Director, Immunoassay Center, Havana
CN206892111U (en) Detect the test strips of duck tembusu virus antibody

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20090909